DarioHealth Corp.

For the period ended Jan 29, 2026. Filed Jan 29, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Jan 29, 2026 · Filed Jan 29, 2026

Use the contents to explore the available documents and sections.

DRIO$2.38-12.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

PROXY STATEMENT

proxy statement. The votes were as follows:

For	Against	Abstain	Broker Non-Votes
4,070,845	107,691	4,325	797,472

Proposal No. 7 — Charter Amendment Proposal.

The stockholders voted to amend and restate the Company’s Certificate of Incorporation granting the Company’s board of directors the right to amend the Company’s bylaws. The votes were as follows:

For	Against	Abstain
4,903,748	69,686	6,899

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 29, 2026	DARIOHEALTH CORP.
	By:	/s/ Chen Franco-Yehuda
		Name: Chen Franco-Yehuda
		Title: Chief Financial Officer, Treasurer and Secretary

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.